Delivery Order SPE2DB20D3303-SPE2DB25FZ8F2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,420.56 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection,...
- The Defense Logistics Agency awarded a delivery order valued at $20,483.16 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on December 4, 2025, with a completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a $15,696.60 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $36,289.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of July 22, 2025. This non-set-aside contract was competitively awarded on July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a brand-name antiretroviral medication used in HIV treatment, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,200.93 to supply BIKTARVY 50-200-25 mg tablets (30-count units) with delivery scheduled for October 23, 2025. This non-competitive, firm fixed-price delivery order was issued on October 22, 2025 and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. BIKTARVY is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $17,855.27 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on July 22, 2025, with completion expected by July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an HIV treatment medication, reflecting the federal government's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a $46,661.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units). This competitive award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, representing a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $74,948.97 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in HIV treatment,...
- The Defense Logistics Agency awarded a $53,530.13 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets (30-count units) with an ultimate completion date of October 23, 2025. This non-set-aside competitive award was issued on October 22, 2025, to be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is a prescription antiretroviral medication used in the treatment of HIV, reflecting the...
- The Defense Logistics Agency awarded a $34,128.88 delivery order (Contract No. 4570304450) to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 tablets (30-count supply) on December 17, 2025, with completion expected by January 15, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of human...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FZ8F2Delivery Order
The Defense Logistics Agency awarded a $20,745.81 delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) on May 19, 2025, with an ultimate completion date of May 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. BIKTARVY is an antiretroviral medication used in the treatment of HIV infection, reflecting the Defense Logistics Agency's ongoing need to maintain pharmaceutical supplies for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order exemplifies the company's recurring role in fulfilling specialized pharmaceutical requirements through the DLA's supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.7k | 5/19/25 |